Clene to Present at Upcoming September Investor Conferences
Clene Inc., a late clinical-stage biopharmaceutical company focused on neurodegenerative diseases, will present at the 2026 Cantor Global Healthcare Conference and the H.C. Wainwright 28th Annual Global Investment Conference in September 2026. Management will host one-on-one meetings and presentations, with webcasts available for investors.